Raman spectroscopic techniques to detect ovarian cancer biomarkers in blood plasma
نویسندگان
چکیده
منابع مشابه
Current clinical application of serum biomarkers to detect ovarian cancer
For the last decades, hundreds of potential serum biomarkers have been assessed in diagnosing of ovarian cancer including the wide spectrum of cytokines, growth factors, adhesion molecules, proteases, hormones, coagulation factors, acute phase reactants, and apoptosis factors but except CA125 none of them have been applied to everyday clinical practice. Nowadays, the growing number of evidence ...
متن کاملPlasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
BACKGROUND Most (70%) epithelial ovarian cancers (EOCs) are diagnosed late. Non-invasive biomarkers that facilitate disease detection and predict outcome are needed. The microRNAs (miRNAs) represent a new class of biomarkers. This study was to identify and validate plasma miRNAs as biomarkers in EOC. METHODOLOGY/PRINCIPAL FINDINGS We evaluated plasma samples of 360 EOC patients and 200 health...
متن کاملStructural Analysis of Hirudin Using FT-IR and FT-Raman Spectroscopic Techniques
FT-IR and FT-Raman spectra of hirudin have been recorded from the native solid hirudin. The conformation of the molecule has been discussed on the basis of IR and Raman data. It has been concluded that hirudin molecule has a mixed a-helix and random coil conformation.
متن کاملOvarian cancer biomarkers in urine.
In this issue of Clinical Cancer Research , Ye et al. (1) have taken steps to address the pressing need for the identification of biomarkers for use in detecting ovarian cancer. For the past 30 years, the statistics have remained the same. The majority of women who develop ovarian cancer will die of this disease. It is the fifth leading cause of all female cancerrelated deaths in North America,...
متن کاملMultiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
BACKGROUND Sensitive methods are needed for biomarker discovery and validation. We tested one promising technology, multiplex proximity ligation assay (PLA), in a pilot study profiling plasma biomarkers in pancreatic and ovarian cancer. METHODS We used 4 panels of 6- and 7-plex PLAs to detect biomarkers, with each assay consuming 1 microL plasma and using either matched monoclonal antibody pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Talanta
سال: 2018
ISSN: 0039-9140
DOI: 10.1016/j.talanta.2018.06.084